NCT05062538Completed
Cancer Patient Perspectives During COVID-19
Patient Perspectives in Breast Cancer Care During COVID-19
Source: ClinicalTrials.gov · Last updated 26 Jul 2024
Brief summary (registry, in English)
A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 89 (actual)
- First submitted
- 29 Sept 2021
- Start date
- 24 Aug 2020
- Primary completion date
- 20 Feb 2021
- Lead sponsor
- University of Colorado, Denver
- NCT number
- NCT05062538
What you commit to
- Study type: Observational
- Participants enrolled: 89
- From 24 Aug 2020 to the primary completion date, 20 Feb 2021
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with non-cancer diagnoses
- Patients with no history of breast cancer
Other
- Males
Who the study is looking for
- Adult females with diagnosis of invasive breast cancer or ductal carcinoma in situ, seen as surgical consultation between 06/01/19-06/01/20
Age in the registry: 18 years to 60 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Colorado Research Center Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.